Stay updated on Nivolumab for Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Meningioma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record now shows 'Results Submitted' instead of 'No Results Posted,' indicating that results for the trial are being prepared for release.
    Difference
    0.0%
    Check dated 2025-12-09T19:22:57.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no visible changes to the study details or layout.
    Difference
    0.0%
    Check dated 2025-11-25T11:53:39.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    - The top government funding/status banner was removed. The study details and eligibility information on the page remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:17:59.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor UI/formatting updates observed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:16:58.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    2%
    Check dated 2025-10-06T05:47:55.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Major update of the page content to include expanded immune biology terms and a new revision version (v3.1.0) replacing v3.0.2.
    Difference
    0.8%
    Check dated 2025-09-29T03:08:07.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.